AIMC Topic: Drug Discovery

Clear Filters Showing 1151 to 1160 of 1689 articles

Applications of machine learning in GPCR bioactive ligand discovery.

Current opinion in structural biology
GPCRs constitute the largest druggable family having targets for 475 Food and Drug Administration (FDA) approved drugs. As GPCRs are of great interest to pharmaceutical industry, enormous efforts are being expended to find relevant and potent GPCR li...

Computational advances in combating colloidal aggregation in drug discovery.

Nature chemistry
Small molecule effectors are essential for drug discovery. Specific molecular recognition, reversible binding and dose-dependency are usually key requirements to ensure utility of a novel chemical entity. However, artefactual frequent-hitter and assa...

Relation path feature embedding based convolutional neural network method for drug discovery.

BMC medical informatics and decision making
BACKGROUND: Drug development is an expensive and time-consuming process. Literature-based discovery has played a critical role in drug development and may be a supplementary method to help scientists speed up the discovery of drugs.

Serendipity-A Machine-Learning Application for Mining Serendipitous Drug Usage From Social Media.

IEEE transactions on nanobioscience
Serendipitous drug usage refers to the unexpected relief of comorbid diseases or symptoms when taking medication for a different known indication. Historically, serendipity has contributed significantly to identifying many new drug indications. If pa...

Heterologous Machine Learning for the Identification of Antimicrobial Activity in Human-Targeted Drugs.

Molecules (Basel, Switzerland)
The emergence of microbes resistant to common antibiotics represent a current treat to human health. It has been recently recognized that non-antibiotic labeled drugs may promote antibiotic-resistance mechanisms in the human microbiome by presenting ...

Automated discovery of GPCR bioactive ligands.

Current opinion in structural biology
While G-protein-coupled receptors (GPCRs) constitute the largest class of membrane proteins, structures and endogenous ligands of a large portion of GPCRs remain unknown. Because of the involvement of GPCRs in various signaling pathways and physiolog...

Elucidating the druggability of the human proteome with eFindSite.

Journal of computer-aided molecular design
Identifying the viability of protein targets is one of the preliminary steps of drug discovery. Determining the ability of a protein to bind drugs in order to modulate its function, termed the druggability, requires a non-trivial amount of time and r...

A combined drug discovery strategy based on machine learning and molecular docking.

Chemical biology & drug design
Data mining methods based on machine learning play an increasingly important role in drug design and discovery. In the current work, eight machine learning methods including decision trees, k-Nearest neighbor, support vector machines, random forests,...